Gentles; Robert G.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Gentles; Robert G..The latest application filed is for "naphthyridinone compounds useful as t cell activators".
Company Profile
4.28.32
- Gentles; Robert G. - Killingworth CT
- Gentles; Robert G. - Wallingford CT
- Gentles; Robert G. - Libertyville IL
Patent Activity
| Patent | Date |
|---|---|
| Naphthyridinone Compounds Useful As T Cell Activators App 20210277004 - Chupak; Louis S. ; et al. | 2021-09-09 |
| Substituted Bicyclic Compounds Useful As T Cell Activators App 20210188845 - Gentles; Robert G. ; et al. | 2021-06-24 |
| Substituted naphthyridinone compounds useful as T cell activators Grant 10,954,238 - Velaparthi , et al. March 23, 2 | 2021-03-23 |
| Substituted naphthyridinone compounds useful as T cell activators Grant 10,669,272 - Velaparthi , et al. | 2020-06-02 |
| Substituted Naphthyridinone Compounds Useful As T Cell Activators App 20200109140 - VELAPARTHI; Upender ; et al. | 2020-04-09 |
| Inhibitors of human immunodeficiency virus replication Grant 10,221,129 - Bender , et al. | 2019-03-05 |
| Inhibitors of human immunodeficiency virus replication Grant 10,035,760 - Pendri , et al. July 31, 2 | 2018-07-31 |
| Inhibitors Of Human Immunodeficiency Virus Replication App 20180086697 - BENDER; John A. ; et al. | 2018-03-29 |
| Inhibitors of human immunodeficiency virus replication Grant 9,855,230 - Belema , et al. January 2, 2 | 2018-01-02 |
| Inhibitors Of Human Immunodeficiency Virus Replication App 20170304239 - BELEMA; Makonen ; et al. | 2017-10-26 |
| Inhibitors Of Human Immunodeficiency Virus Replication App 20160257645 - Pendri; Annapurna ; et al. | 2016-09-08 |
| Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors App 20140186299 - Bender; John A. ; et al. | 2014-07-03 |
| Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors App 20140045816 - Bender; John A. ; et al. | 2014-02-13 |
| Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors App 20130171098 - Bender; John A. ; et al. | 2013-07-04 |
| Glycine chroman-6-sulfonamides for use as inhibitors of diacylglycerol lipase Grant 8,404,741 - Chupak , et al. March 26, 2 | 2013-03-26 |
| Glycine chroman-6-sulfonamides for use as inhibitors of diacylglycerol lipase Grant 8,354,548 - Hu , et al. January 15, 2 | 2013-01-15 |
| Compounds for the treatment of hepatitis C Grant 8,143,243 - Martin , et al. March 27, 2 | 2012-03-27 |
| Compounds for the treatment of hepatitis C Grant 8,133,884 - Martin , et al. March 13, 2 | 2012-03-13 |
| Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors App 20110311480 - Bender; John A. ; et al. | 2011-12-22 |
| Glycine Chroman-6-Sulfonamides for Use as Inhibitors of Diacylglycerol Lipase App 20110207772 - Hu; Shuanghua ; et al. | 2011-08-25 |
| Glycine Chroman-6-Sulfonamides for Use as Inhibitors of Diacylglycerol Lipase App 20110207749 - Chupak; Louis S. ; et al. | 2011-08-25 |
| Compounds for the treatment of hepatitis C Grant 7,652,004 - Martin , et al. January 26, 2 | 2010-01-26 |
| Compounds for the Treatment of Hepatitis C App 20090280083 - Martin; Scott W. ; et al. | 2009-11-12 |
| Compounds for the Treatment of Hepatitis C App 20090275561 - Martin; Scott W. ; et al. | 2009-11-05 |
| Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors App 20090162318 - Bender; John A. ; et al. | 2009-06-25 |
| Compounds for the treatment of Hepatitis C Grant 7,547,690 - Gentles , et al. June 16, 2 | 2009-06-16 |
| Compounds for the treatment of hepatitis C Grant 7,541,353 - Gentles , et al. June 2, 2 | 2009-06-02 |
| Compounds for the treatment of hepatitis C Grant 7,541,351 - Bender , et al. June 2, 2 | 2009-06-02 |
| Compounds for the treatment of Hepatitis C Grant 7,538,102 - Yeung , et al. May 26, 2 | 2009-05-26 |
| Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors Grant 7,521,442 - Gentles , et al. April 21, 2 | 2009-04-21 |
| Compounds for the treatment of hepatitis C Grant 7,521,444 - Bender , et al. April 21, 2 | 2009-04-21 |
| Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors Grant 7,521,441 - Gentles , et al. April 21, 2 | 2009-04-21 |
| Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors Grant 7,521,443 - Bender , et al. April 21, 2 | 2009-04-21 |
| Compounds for the Treatment of Hepatitis C App 20090074715 - Martin; Scott W. ; et al. | 2009-03-19 |
| Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors Grant 7,485,633 - Meanwell , et al. February 3, 2 | 2009-02-03 |
| Indolobenzazepine HCV NS5B inhibitors Grant 7,473,688 - Bergstrom , et al. January 6, 2 | 2009-01-06 |
| Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors Grant 7,456,166 - Bender , et al. November 25, 2 | 2008-11-25 |
| Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors Grant 7,452,876 - Yeung , et al. November 18, 2 | 2008-11-18 |
| Compounds for the Treatment of Hepatitis C App 20080226591 - Gentles; Robert G. ; et al. | 2008-09-18 |
| Compounds for the Treatment of Hepatitis C App 20080226590 - Bender; John A. ; et al. | 2008-09-18 |
| Compounds for the Treatment of Hepatitis C App 20080227769 - Gentles; Robert G. ; et al. | 2008-09-18 |
| Compounds for the Treatment of Hepatitis C App 20080226592 - Yeung; Kap-Sun ; et al. | 2008-09-18 |
| Compounds for the Treatment of Hepatitis C App 20080171015 - Bender; John A. ; et al. | 2008-07-17 |
| Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors Grant 7,399,758 - Meanwell , et al. July 15, 2 | 2008-07-15 |
| Cyclopropyl Fused Indolobenzazepine Hcv Ns5b Inhibitors App 20080146537 - Bender; John A. ; et al. | 2008-06-19 |
| Inhibitors of HCV replication Grant 7,348,425 - Hudyma , et al. March 25, 2 | 2008-03-25 |
| Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors App 20070287694 - Yeung; Kap-Sun ; et al. | 2007-12-13 |
| Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors App 20070275930 - Gentles; Robert G. ; et al. | 2007-11-29 |
| Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors App 20070270406 - Gentles; Robert G. ; et al. | 2007-11-22 |
| Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors App 20070270405 - Bender; John A. ; et al. | 2007-11-22 |
| Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors App 20070184024 - Meanwell; Nicholas A. ; et al. | 2007-08-09 |
| Indolobenzazepine HCV NS5B inhibitors App 20070078122 - Bergstrom; Carl P. ; et al. | 2007-04-05 |
| Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors App 20070060565 - Meanwell; Nicholas A. ; et al. | 2007-03-15 |
| Inhibitors of HCV replication Grant 7,153,848 - Hudyma , et al. December 26, 2 | 2006-12-26 |
| Inhibitors of HCV replication App 20060166964 - Hudyma; Thomas W. ; et al. | 2006-07-27 |
| Inhibitors of HCV replication App 20060046983 - Hudyma; Thomas W. ; et al. | 2006-03-02 |
| Cyclic and bicyclic diamino histamine-3 receptor antagonists Grant 6,559,140 - Bennani , et al. May 6, 2 | 2003-05-06 |
| Cyclic and bicyclic diamino histamine-3 receptor antagonists App 20010049367 - Bennani, Youssef L. ; et al. | 2001-12-06 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 